Share Email Print

Proceedings Paper

Optical fibers with enhanced performance for excimer laser power transmission at 308 nm
Author(s): Heinz Fabian; Ulrich Grzesik; Georg Hillrichs; Walter Neu
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Power transmission of xenon chloride excimer lasers through optical fibers is necessary for medical applications where tissue removal is performed within the human body. The most important application at present is excimer laser coronary angioplasty. Typical levels of energy densities applied by optical fibers for this application cause color center generation in fused silica leading to transmission decrease called photodegradation. This effect depends essentially on the grade of the fused silica. Important parameters are fiber length, pulse duration, energy density, and the irradiated cross sectional area of the optical fiber endface. For a new grade of core material the influence of these parameters on the transmission performance is described. The obtained material improvement leads to a significant reduction of the observable transmission decrease as a function of the number of laser pulses applied. Thus continuous operation of the laser in the region of the typical transmission plateaus at considerably higher and constant energy levels at the distal fiber end becomes feasible. This offers a new option for more reliable dosimetry in medical applications.

Paper Details

Date Published: 28 May 1993
PDF: 9 pages
Proc. SPIE 1893, Optical Fibers in Medicine VIII, (28 May 1993); doi: 10.1117/12.146349
Show Author Affiliations
Heinz Fabian, Heraeus Quarzglas GmbH (Germany)
Ulrich Grzesik, Heraeus Quarzglas GmbH (Germany)
Georg Hillrichs, Laser Lab. Goettingen e.V. (Germany)
Walter Neu, Laser Lab. Goettingen e.V. (Germany)

Published in SPIE Proceedings Vol. 1893:
Optical Fibers in Medicine VIII
Abraham Katzir, Editor(s)

© SPIE. Terms of Use
Back to Top